Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

sanofi-aventis US, Bridgewater

Sanofi-Aventis, Buenos Aires

sanofi-aventis, Australia, Macquarie Park

Sanofi-Aventis, Vienna

sanofi-aventis, Belgium, Diegem

Sanofi-Aventis, Rio de Janeiro

sanofi-aventis Canada, Laval

sanofi-aventis, France, Paris

sanofi-aventis Germany, Berlin

sanofi-aventis Greece, Athens

Sanofi-Aventis, Basse-Terre

Sanofi-Aventis Hungaria, Budapest

sanofi-aventis Israel, Netanya

sanofi-aventis Italy, Milan

Sanofi-Aventis, Saint-Denis

Sanofi-Aventis, Moscow

sanofi-aventis South Africa, Midrand

Sanofi-Aventis, Madrid

sanofi-aventis Switzerland, Geneva

Sanofi-Aventis, Montevideo